| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| LOTUS VENTURES Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 2,380 | +1,62 % | Aurora Cannabis Inc (3): Aurora Cannabis mails management information circular | ||
| CANOPY GROWTH | 0,864 | +2,39 % | Is Canopy Growth Stock Finally Worth Buying After Losing 99% of Its Value? | ||
| TILRAY BRANDS | 3,855 | +0,65 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 03.07.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| INNOCAN PHARMA | 1,745 | -8,16 % | InnoCan Pharma zieht durch: Die Entwicklung die jetzt niemand auf dem Schirm hat - Handeln Sie, bevor es zu spät ist! | ||
| CRONOS GROUP | 2,386 | -1,08 % | Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders | TORONTO, June 22, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") today announced that at its Annual Meeting of Shareholders held on Thursday, June... ► Artikel lesen | |
| DIGICANN VENTURES | 0,002 | -92,31 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,876 | +2,34 % | Organigram Global Inc.: Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities | Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram") and Sanity Group GmbH ("Sanity" or "Sanity Group") jointly announced the successful closing of Organigram's previously... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 6,550 | +0,92 % | Is Green Thumb Stock Oversold? The Case for 100% Upside. | ||
| SNDL | 1,141 | +0,71 % | 1CM Inc.: 1CM Provides Update on Arrangement Agreement with SNDL | Toronto, Ontario--(Newsfile Corp. - May 27, 2026) - 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") announces that it does not expect the proposed sale of its Ontario retail locations to... ► Artikel lesen | |
| CRESCO LABS | 0,710 | +1,72 % | Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026 | Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) ("Cresco" or "Company"), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of... ► Artikel lesen | |
| NOVERIS HEALTH SCIENCES | 1,020 | +5,70 % | XFRA 0NF1: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| WAYLAND GROUP | - | - | EQS-News: Berger Montague (Canada) PC: Ankündigung der Anhörung zur Genehmigung des Vergleichs - Wayland Group Corp., Scott Langille, Gerhard Müller, Paul Pathak, Eric Silver, M. Stein, John Does 1-3, Canaccord Genuity Corp. und RF Securities Clearing LP | EQS-News: Berger Montague (Canada) PC
/ Schlagwort(e): Rechtssache/Sonstiges
ANKÜNDIGUNG DER ANHÖRUNG ZUR GENEHMIGUNG DES VERGLEICHS - KURZFASSUNG - WAYLAND... ► Artikel lesen | |
| QUANTUM BIOPHARMA | 2,710 | -1,74 % | Quantum BioPharma Provides Corporate Update | THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, July 07, 2026... ► Artikel lesen | |
| AXSOME THERAPEUTICS | 216,40 | +0,74 % | Axsome Therapeutics, Inc.: Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder (ADHD) | The FOCUS-2 trial in children complements the recently announced FOCUS-3 trial in adolescents with ADHD NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical... ► Artikel lesen | |
| FINCANNA CAPITAL | 0,001 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.01.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 28.01.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.01.2026.ISIN NameCA31773B5018 FINCANNA... ► Artikel lesen |